CAMP4 Therapeutics (CAMP) vs Enanta Pharmaceuticals (ENTA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
CAMP4 Therapeutics (CAMP) has outperformed Enanta Pharmaceuticals (ENTA) over the past year, gaining 30.7% versus a loss of 40.1%. CAMP4 Therapeutics is the larger company by market cap ($237.8 million vs $222.2 million), about 1.1 times the size. Enanta Pharmaceuticals converts more of its revenue into profit, with a net margin of -108.3% versus -2298.5%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CAMP | ENTA |
|---|---|---|
| Share price | $3.79 | $7.62 |
| Market cap | $237.84M | $222.19M |
| 1-day change | -5.25% | -4.51% |
| YTD return | -38.17% | -51.68% |
| 1-year return | +30.69% | -40.14% |
| 5-year return | — | -91.71% |
| EPS (TTM) | $-2.11 | $-2.35 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $3.50M | $63.00M |
| Revenue growth (YoY) | +436.50% | -3.56% |
| Net income (latest FY) | $-80.40M | $-68.25M |
| Operating margin | -1502.43% | -99.01% |
| Net margin | -2298.54% | -108.33% |
| 52-week high | $7.75 | $17.15 |
| 52-week low | $2.90 | $7.56 |
| Distance from 52-week high | -51.10% | -55.57% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +169.66% | +186.48% |
| Average volume | 238.88K | 287.81K |
| Shares outstanding | 62.75M | 29.16M |
| Employees | 48 | 120 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CAMP has outperformed ENTA by 70.8 percentage points over the past year.
- Enanta Pharmaceuticals is more profitable, keeping -108.3 cents of every revenue dollar as net income versus -2298.5 cents for CAMP4 Therapeutics.
- CAMP4 Therapeutics grew revenue faster in its latest fiscal year (+436.50% vs -3.56%).
About CAMP4 Therapeutics
CAMP stock →Camp4 Therapeutics Corporation, a clinical-stage biopharmaceutical company, discovers and develops RNA-based therapeutics to treat a range of genetic diseases. Its lead product candidate is CMP-001, which is in a Phase 1/2 clinical trial for the treatment of urea cycle disorders.
Health Care · Biotechnology: Pharmaceutical Preparations · 48 employees
About Enanta Pharmaceuticals
ENTA stock →Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for virology and immunology indications. The company's product pipeline comprises EDP-514, which is in phase 1b clinical development for the treatment of chronic infection with hepatitis B virus or HBV; zelicapavir and EDP-323, which is in phase II clinical development for the treatment of respiratory syncytial virus; EDP-235, which is in phase II clinical development for the treatment of human coronaviruses; EDP-978 for chronic spontaneous urticaria (CSU); Glecaprevir, antiviral protease inhibitors for the treatment of chronic infection with hepatitis C virus or HCV; and EPS-3903 for the treatment of atopic dermatitis.
Health Care · Biotechnology: Pharmaceutical Preparations · 120 employees
CAMP vs ENTA FAQ
Which is bigger, CAMP4 Therapeutics or Enanta Pharmaceuticals?
CAMP4 Therapeutics (CAMP) is larger, with a market capitalization of $237.84M compared with $222.19M for Enanta Pharmaceuticals (ENTA).
Which stock has performed better over the past year, CAMP or ENTA?
CAMP returned +30.69% over the past 12 months, compared with -40.14% for ENTA (price return, excluding dividends). Past performance does not predict future results.
Are CAMP4 Therapeutics and Enanta Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.